Medicare Part D copays are set to rise on branded drugs

11/21/2011 | Sioux City Journal (Iowa)

Out-of-pocket costs that Medicare Part D enrollees will pay next year for brand-name drugs will rise by an average of 40% for preferred drugs and 30% for nonpreferred drugs, according to an Avalere Health study. Copays for nonpreferred generic drugs will drop by about 43% and will stay about the same for preferred generics, the study found.

View Full Article in:

Sioux City Journal (Iowa)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID